Product
Ferric citrate
Aliases
ferric citrate, KRX-0502
Name
Auryxia
INN Name
ferric citrate
FDA Approved
Yes
2 clinical trials
1 organization
3 indications
1 document
Indication
HyperphosphatemiaIndication
End-Stage Renal DiseaseClinical trial
A 36-week, Single-Arm, Open-label Study to Evaluate the Safety and Tolerability of Ferric Citrate in Children With Hyperphosphatemia Related to Chronic Kidney DiseaseStatus: Recruiting, Estimated PCD: 2025-01-01
Clinical trial
A Study to Evaluate the Efficacy and Safety of Ferric Citrate Tablet for the Treatment of Hyperphosphatemia in Patients With Chronic Kidney Disease Undergoing HemodialysisStatus: Completed, Estimated PCD: 2022-09-13
Document
DailyMed Label: AuryxiaOrganization
Akebia Therapeutics, Inc.